Trans-resveratrol reduces visible signs of skin ageing in healthy adult females over 40: an 8-week randomized placebo-controlled trial.
- 2025-12-19
- Clinical Trial · n = 134
- Frontiers in aging 6
- Amanda Rao
- David Briskey
- Georgia Roche
- Annie Tremblay
- Marcia Da Silva Pinto
- Thomas A Tompkins
- PubMed: 41488277
- DOI: 10.3389/fragi.2025.1727244
- High evidence
- Mixed
the active topical groups (P/A and A/A Groups) having significantly higher U-zone sebum at week 8 compared to placebo topical groups.
- Effect
- Beneficial
- Effect size
- Small
- Significant
- Yes
- Dose
- 75 mg orally twice daily and/or 1.5% topical cream twice daily